Literature DB >> 10655399

Effect of a Mycoplasma hominis-like Mycoplasma on the infection of HEp-2 cells by the TW-183 strain of Chlamydia pneumoniae.

E A Castilla1, R M Wadowsky.   

Abstract

We isolated a Mycoplasma hominis-like mycoplasma from a stock culture of Chlamydia pneumoniae TW-183 obtained from the American Type Culture Collection and eradicated the contaminant by treating the stock suspension with a nonionic detergent, Igepal CA-630. The M. hominis-like mycoplasma neither inhibits nor enhances the infectivity of C. pneumoniae for HEp-2 cells.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10655399      PMCID： PMC86224     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  8 in total

1.  Use of HEp-2 cells for improved isolation and passage of Chlamydia pneumoniae.

Authors:  P M Roblin; W Dumornay; M R Hammerschlag
Journal:  J Clin Microbiol       Date:  1992-08       Impact factor: 5.948

2.  Amino acid requirements for growth of Chlamydia pneumoniae in cell cultures: growth enhancement by lysine or methionine depletion.

Authors:  C C Kuo; J T Grayston
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

Review 3.  Mycoplasmas and cell cultures.

Authors:  E Stanbridge
Journal:  Bacteriol Rev       Date:  1971-06

4.  Mycoplasma contamination of Chlamydia pneumoniae isolates.

Authors:  B S Huniche; L T Jensen; S Birkelund; G Christiansen
Journal:  Scand J Infect Dis       Date:  1998

5.  Widely used, commercially available Chlamydia pneumoniae antigen contaminated with mycoplasma.

Authors:  R P Verkooyen; M Sijmons; E Fries; A Van Belkum; H A Verbrugh
Journal:  J Med Microbiol       Date:  1997-05       Impact factor: 2.472

6.  Diagnosis of Mycoplasma pneumoniae pneumonia: sensitivities and specificities of serology with lipid antigen and isolation of the organism on soy peptone medium for identification of infections.

Authors:  G E Kenny; G G Kaiser; M K Cooney; H M Foy
Journal:  J Clin Microbiol       Date:  1990-09       Impact factor: 5.948

7.  Application of a Mycoplasma group-specific PCR for monitoring decontamination of Mycoplasma-infected Chlamydia sp. strains.

Authors:  J M Ossewaarde; A de Vries; T Bestebroer; A F Angulo
Journal:  Appl Environ Microbiol       Date:  1996-02       Impact factor: 4.792

8.  Mycoplasma contamination of chlamydiae isolated from clinical specimens.

Authors:  T O Messmer; C M Black; W L Thacker
Journal:  APMIS       Date:  1994-10       Impact factor: 3.205
  8 in total
  4 in total

1.  Mycoplasma fermentans, M. hominis, and M. hyorhinis inhibit infectivity and growth of Chlamydia trachomatis and C. pneumoniae in HEp-2 cells.

Authors:  B Krausse-Opatz; P Dollmann; H Zeidler; L Köhler; J G Kuipers
Journal:  J Clin Microbiol       Date:  2000-10       Impact factor: 5.948

2.  Chlamydia pneumoniae infection induces differentiation of monocytes into macrophages.

Authors:  Hiroyuki Yamaguchi; Shusaku Haranaga; Ray Widen; Herman Friedman; Yoshimasa Yamamoto
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

3.  Mycoplasma decontamination in Chlamydia trachomatis culture: a curative approach.

Authors:  Madison Greer; Jacob H Elnaggar; Christopher M Taylor; Li Shen
Journal:  Pathog Dis       Date:  2022-01-12       Impact factor: 3.166

4.  Trypanosoma cruzi Differentiates and Multiplies within Chimeric Parasitophorous Vacuoles in Macrophages Coinfected with Leishmania amazonensis.

Authors:  Carina Carraro Pessoa; Éden Ramalho Ferreira; Ethel Bayer-Santos; Michel Rabinovitch; Renato Arruda Mortara; Fernando Real
Journal:  Infect Immun       Date:  2016-04-22       Impact factor: 3.441
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.